Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

Author:

Alvarnas Joseph C.1,Le Rademacher Jennifer2,Wang Yanli3,Little Richard F.4,Akpek Gorgun5,Ayala Ernesto6,Devine Steven7,Baiocchi Robert7,Lozanski Gerard7,Kaplan Lawrence8,Noy Ariela9,Popat Uday10,Hsu Jack11,Morris Lawrence E.12,Thompson Jason3,Horowitz Mary M.2,Mendizabal Adam3,Levine Alexandra13,Krishnan Amrita1,Forman Stephen J.1,Navarro Willis H.14,Ambinder Richard15

Affiliation:

1. Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA;

2. Center for International Blood & Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI;

3. The Emmes Corporation, Rockville, MD;

4. Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD;

5. Greenebaum Cancer Center, University of Maryland Medical Systems, Baltimore, MD;

6. Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL;

7. Department of Hematology, The Ohio State University–Arthur G. James Cancer Center Hospital, Columbus, OH;

8. Division of Hematology/Oncology, University of California, San Francisco, CA;

9. Division of Hematological Oncology, Memorial Sloan Kettering Cancer Center, New York, NY;

10. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;

11. Bone Marrow Transplant Program, University of Florida Health Cancer Center, Gainesville, FL;

12. The Blood and Marrow Transplant Group of Georgia, Northside Hospital Cancer Institute, Atlanta, GA;

13. City of Hope National Medical Center, Duarte, CA;

14. National Marrow Donor Program, Minneapolis, MN; and

15. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD

Abstract

Key PointsAutologous hematopoietic cell transplantation is safe and effective in patients with HIV-related lymphoma who meet standard transplant criteria. Patients with HIV-related lymphomas should not be precluded from participating in AHCT clinical trials.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3